Physician profile
Dennis Jones
NPI 1649332149
$413.90
in general payments reported to CMS, 2019-2025
13 companies · $41.41 in 2025
The $41.41 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $182 · 2022: $136 · 2023: $54.84 · 2025: $41.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $96.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $96.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $170.61 | 2021-2022 | |
| Depuy Synthes Sales INC. | $40.73 | 2023 | Na |
| Theragen, INC. | $28.18 | 2022-2023 | Kneehab Xp |
| Heron Therapeutics, INC. | $24.44 | 2021 | |
| Djo, LLC | $22.92 | 2025 | Cmf |
| Vericel Corporation | $22.74 | 2021 | |
| Smith+Nephew, INC. | $19.47 | 2021 | |
| Coastal Medical Technologies LLC | $18.49 | 2025 | |
| Sanofi-Aventis U.S. LLC | $17.00 | 2022 | |
| Almatica Pharma LLC | $16.48 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.43 | 2022 | |
| Nevro Corp. | $16.41 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.